Research Article
Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
Table 2
Clinical remission, mucosal healing, and quality of life scores according to infliximab levels.
| | Disease control | | | value | | n | % | n | % |
| | Clinical remission | 24 | 85.7 | 12 | 27.9 | <0.001 | | Mucosal healing | 24 | 85.7 | 8 | 18.6 | <0.001 |
| | Quality-of-life score | Mean | ±SD | Mean | ±SD | |
| | Bowel symptoms () | 59.6 | 9.3 | 52.3 | 8.5 | 0.001 | | Systemic function () | 27.3 | 5.6 | 22.7 | 5.2 | 0.001 | | Social function () | 30.8 | 5.7 | 26.7 | 7.4 | 0.015 | | Emotional status () | 65.1 | 16.5 | 60.0 | 12.9 | 0.148 | | Global () | 183.0 | 32.6 | 161.9 | 28.9 | 0.006 |
|
|
